|
|||||
|
Back | Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 25 | Sale | 17.54 | 1,367 | 23,980 | 77,444 | Mar 26 08:08 PM |
CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 09 | Option Exercise | 0.00 | 2,666 | 0 | 75,791 | Mar 19 07:50 PM |
CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 11 | Sale | 16.35 | 1,418 | 23,188 | 74,373 | Mar 19 07:50 PM |
CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 15 | Sale | 15.43 | 1,312 | 20,247 | 73,061 | Mar 19 07:50 PM |
CYRX | Sawicki Mark W | Chief Scientific Officer | Sep 12 | Option Exercise | 12.79 | 1,000 | 12,790 | 73,125 | Sep 13 05:01 PM |
CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 15 | Sale | 20.79 | 1,362 | 28,316 | 61,670 | Mar 17 04:15 PM |
CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 09 | Option Exercise | 0.00 | 2,667 | 0 | 64,508 | Mar 13 09:24 PM |
CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 13 | Sale | 20.14 | 1,476 | 29,727 | 63,032 | Mar 13 09:24 PM |
CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 09 | Option Exercise | 0.00 | 2,667 | 0 | 52,796 | Mar 11 05:45 PM |
CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 09 | Sale | 31.05 | 1,410 | 43,780 | 51,386 | Mar 11 05:45 PM |
CYRX | Sawicki Mark W | Chief Scientific Officer | Aug 11 | Option Exercise | 7.95 | 94,202 | 748,866 | 130,275 | Aug 13 04:46 PM |
CYRX | Sawicki Mark W | Chief Scientific Officer | Aug 11 | Sale | 58.45 | 80,146 | 4,684,473 | 50,129 | Aug 13 04:46 PM |
CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 10 | Option Exercise | 2.84 | 30,404 | 86,319 | 49,404 | Mar 11 09:09 PM |
CYRX | Sawicki Mark W | Chief Scientific Officer | Mar 10 | Sale | 55.13 | 13,331 | 734,934 | 36,073 | Mar 11 09:09 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite